Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series

Abstract Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, small vessel, necrotizing vasculitis. The disease is mainly characterized by hypereosinophilia and asthma with frequent sinonasal involvement, although multiple organs can be affected, including the heart, lungs, skin, gastroin...

Full description

Bibliographic Details
Main Authors: Aikaterini Detoraki, Eugenio Tremante, Remo Poto, Emanuela Morelli, Giuseppe Quaremba, Francescopaolo Granata, Antonio Romano, Ilaria Mormile, Francesca Wanda Rossi, Amato de Paulis, Giuseppe Spadaro
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Respiratory Research
Subjects:
Eosinophilic granulomatosis with polyangiitis
Severe eosinophilic asthma
Chronic rhinosinusitis
Nasal polyposis
Mepolizumab
Online Access:https://doi.org/10.1186/s12931-021-01775-z

Internet

https://doi.org/10.1186/s12931-021-01775-z

Similar Items